Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate

Pregnant women with hyperthyroidism need careful management, which is due to the increased risk of maternal and fetal complications. However, safe and effective therapies for hyperthyroidism during pregnancy remain limited. Carbimazole is an anti-thyroid agent and has been used to treat hyperthyroid...

Descripción completa

Detalles Bibliográficos
Autores principales: Asfour, Suzan S, Al-Mouqdad, Mountasser M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Obstetrics/Gynecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170418/
https://www.ncbi.nlm.nih.gov/pubmed/35686264
http://dx.doi.org/10.7759/cureus.24808
_version_ 1784721420756975616
author Asfour, Suzan S
Al-Mouqdad, Mountasser M
author_facet Asfour, Suzan S
Al-Mouqdad, Mountasser M
author_sort Asfour, Suzan S
collection PubMed
description Pregnant women with hyperthyroidism need careful management, which is due to the increased risk of maternal and fetal complications. However, safe and effective therapies for hyperthyroidism during pregnancy remain limited. Carbimazole is an anti-thyroid agent and has been used to treat hyperthyroidism. Gastroschisis is a congenital severe abdominal birth defect of the fetus but its etiology remains unclear. Here, we present a case of a female term neonate who developed gastroschisis after being exposed to carbimazole in uteroduring the first and half of the second trimester.
format Online
Article
Text
id pubmed-9170418
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-91704182022-06-08 Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate Asfour, Suzan S Al-Mouqdad, Mountasser M Cureus Obstetrics/Gynecology Pregnant women with hyperthyroidism need careful management, which is due to the increased risk of maternal and fetal complications. However, safe and effective therapies for hyperthyroidism during pregnancy remain limited. Carbimazole is an anti-thyroid agent and has been used to treat hyperthyroidism. Gastroschisis is a congenital severe abdominal birth defect of the fetus but its etiology remains unclear. Here, we present a case of a female term neonate who developed gastroschisis after being exposed to carbimazole in uteroduring the first and half of the second trimester. Cureus 2022-05-07 /pmc/articles/PMC9170418/ /pubmed/35686264 http://dx.doi.org/10.7759/cureus.24808 Text en Copyright © 2022, Asfour et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Obstetrics/Gynecology
Asfour, Suzan S
Al-Mouqdad, Mountasser M
Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title_full Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title_fullStr Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title_full_unstemmed Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title_short Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate
title_sort gastroschisis due to maternal exposure to carbimazole in a term neonate
topic Obstetrics/Gynecology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170418/
https://www.ncbi.nlm.nih.gov/pubmed/35686264
http://dx.doi.org/10.7759/cureus.24808
work_keys_str_mv AT asfoursuzans gastroschisisduetomaternalexposuretocarbimazoleinatermneonate
AT almouqdadmountasserm gastroschisisduetomaternalexposuretocarbimazoleinatermneonate

Ejemplares similares